Division of Developmental Pediatrics, University of AlbertaFASD Clinical and Research Services, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Yan, A, Bell, E, Racine, E.Ethical and social challenges in newborn screening for prenatal alcohol exposure. Can J Neurol Sci. 2014: 41(1):115–18.Google Scholar
2
2.Marcellus, L.Is meconium screening appropriate for universal use. Science and ethics say no. Adv Neonatal Care. 2007;7(4): 207–14.Google Scholar
3
3.MacLeod, S, Koren, G.Meconium testing for fatty acid ethyl esters: a 2011 status report. J Popul Ther Clin Pharmacol. 2011:18(3): e500–2.Google Scholar
4
4.Dickens, B.Legal and ethical considerations in meconium testing for fetal exposure to alcohol. J Popul Ther Clin Pharmacol. 2011; 18(3):e471–4.Google Scholar
5
5.Zelner, I, Shor, S, Lynn, H, Roukema, H, Elsinga, K, Koren, G.Clinical use of meconium fatty ethyl esters for identifying children at risk for alcohol related disabilities: the first reported case. J Popul Ther Clin Pharmacol. 2012;19(1): e26–31.Google ScholarPubMed
6
6.Zelner, I, Hutson, J, Kapur, B, Feig, D, Koren, G.False positive meconium test results for fatty ethyl esters secondary to delayed sample collection. Alcohol Clin Exp Res. 2012;36(9):1497–506.Google Scholar
7
7.FASD Legal Issues Consensus Statement. Alberta Institute of Health Economics; [cited 2013 Sept 20]. Available from: www.ihe.ca.Google Scholar
8
8.Riley, E, Infante, M, Warren, K.Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011;21(2):73–80.Google Scholar
9
9.McLachlan, K, Andrew, G, Pei, J, Rasmussen, C.Assessing FASD in preschoolers. Exploring neurobehavioral profiles and clinical challenges. Presented at the International Conference on FASD, Vancouver, 2013.Google Scholar